Market Overview - As of July 1, 2025, the three major A-share indices showed mixed performance, with the Shanghai Composite Index rising by 0.39% to 3457.75 points, the Shenzhen Component Index increasing by 0.11% to 10476.29 points, and the ChiNext Index declining by 0.24% to 2147.92 points. The total trading volume of the two markets reached 1.47 trillion yuan [1]. Industry Performance - The glass and fiberglass sector performed notably well, surging by 5.11%, followed by professional chains and chemical pharmaceuticals, which rose by 4.04% and 2.96%, respectively [1]. - The overall market saw 562 non-currency ETFs increase, representing 48% of the total [1]. ETF Performance - The Shanghai Stock Exchange Science and Technology Innovation Board Biomedicine Index rose by 2.99%, with various ETFs tracking this index, such as the Science and Technology Medicine ETF and the Science and Technology Biomedicine ETF, showing increases between 3.02% and 3.18% [1]. - The China Securities Hong Kong-Shenzhen Innovation Drug Industry Index increased by 1.13%, with the Innovation Drug ETFs from Fortune and Guotai rising by 5.88% and 3.90%, respectively [1]. Specific ETF Details - The Innovation Drug ETF from Fortune (159748.SZ) has a latest share size of 548 million, closely tracking the China Securities Hong Kong-Shenzhen Innovation Drug Industry Index, which includes major companies like WuXi AppTec and Innovent Biologics [2]. - The latest PE-TTM for the China Securities Hong Kong-Shenzhen Innovation Drug Industry Index is 40.00, which is lower than 82.73% of the time over the past three years [3]. - The Hong Kong Stock Connect Innovation Drug ETF (159570.SZ) has a share size of 5.129 billion and tracks the National Securities Hong Kong Stock Connect Innovation Drug Index, which includes companies like Innovent Biologics and WuXi Biologics [3]. - The Science and Technology Medicine ETF (588860.SH) has a share size of 1.42 billion and tracks the Shanghai Stock Exchange Science and Technology Innovation Board Biomedicine Index, featuring companies such as BeiGene and Hualan Biological Engineering [4]. Declining ETFs - The overall market saw 514 non-currency ETFs decline, accounting for 44% of the total, with the China Securities Financial Technology Theme Index and the China Securities All-Index Software Index experiencing the largest drops of 2.84% and 1.70%, respectively [4]. - The Financial Technology ETF (516860.SH) has a share size of 608 million and tracks the China Securities Financial Technology Theme Index, which includes companies like Eastmoney Information and Tonghuashun [6].
ETF英雄汇：创新药ETF富国(159748.SZ)领涨、港股创新药板块溢价明显-20250701